Europeiska unionen - svenska - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

hisamitsu italia s.r.l. - kamfer, racemisk; levomentol; metylsalicylat - medicinskt plåster - butylhydroxitoluen hjälpämne; levomentol 32,7 mg aktiv substans; metylsalicylat 36,1 mg aktiv substans; kamfer, racemisk 7,1 mg aktiv substans - salicylsyraderivat

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

hisamitsu italia s.r.l. - d-kamfer; hydroxietylsalicylat; levomentol; metylsalicylat - kutan spray, lösning - metylsalicylat 17,5 mg aktiv substans; hydroxietylsalicylat 17,5 mg aktiv substans; d-kamfer 30 mg aktiv substans; levomentol 32 mg aktiv substans - salicylsyraderivat

Europeiska unionen - svenska - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - imidakloprid, moxidektin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). det veterinärmedicinska läkemedlet kan användas som en del av en behandlingsstrategi för loppalergidermatit (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). det veterinärmedicinska läkemedlet kan användas som en del av en behandlingsstrategi för loppalergidermatit (fad).

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

b. braun melsungen ag - alanin; arginin; asparaginsyra; fenylalanin; glukosmonohydrat; glutaminsyra; glycin; histidinhydrokloridmonohydrat; isoleucin; kalciumkloriddihydrat; kaliumacetat; leucin; lysinhydroklorid; magnesiumacetattetrahydrat; metionin; natriumacetattrihydrat; natriumdivätefosfatdihydrat; natriumhydroxid; natriumklorid; omega-3-syratriglycerider; prolin; serin; sojaolja, raffinerad; treonin; triglycerider, medellångkedjiga; tryptofan; valin; zinkacetatdihydrat - infusionsvätska, emulsion - natriumacetattrihydrat 0,554 mg aktiv substans; glycin 3,96 mg aktiv substans; alanin 11,64 mg aktiv substans; serin 7,2 mg aktiv substans; leucin 7,52 mg aktiv substans; metionin 4,7 mg aktiv substans; fenylalanin 8,42 mg aktiv substans; treonin 4,36 mg aktiv substans; tryptofan 1,36 mg aktiv substans; isoleucin 5,64 mg aktiv substans; arginin 6,48 mg aktiv substans; kaliumacetat 6,868 mg aktiv substans; magnesiumacetattetrahydrat 1,716 mg aktiv substans; prolin 8,16 mg aktiv substans; histidinhydrokloridmonohydrat 4,06 mg aktiv substans; lysinhydroklorid 6,82 mg aktiv substans; natriumhydroxid 1,952 mg aktiv substans; asparaginsyra 3,6 mg aktiv substans; glutaminsyra 8,42 mg aktiv substans; natriumklorid 1,006 mg aktiv substans; kalciumkloriddihydrat 1,176 mg aktiv substans; glycerol hjälpämne; omega-3-syratriglycerider 20 mg aktiv substans; triglycerider, medellångkedjiga 100 mg aktiv substans; sojaolja, raffinerad 80 mg aktiv substans; zinkacetatdihydrat 13,16 mikrog aktiv substans; natriumdivätefosfatdihydrat 4,68 mg aktiv substans; glukosmonohydrat 330 mg aktiv substans; valin 6,24 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

b. braun melsungen ag - alanin; arginin; asparaginsyra; fenylalanin; glukosmonohydrat; glutaminsyra; glycin; histidinhydrokloridmonohydrat; isoleucin; kalciumkloriddihydrat; kaliumacetat; leucin; lysinhydroklorid; magnesiumacetattetrahydrat; metionin; natriumacetattrihydrat; natriumdivätefosfatdihydrat; natriumhydroxid; natriumklorid; omega-3-syratriglycerider; prolin; serin; sojaolja, raffinerad; treonin; triglycerider, medellångkedjiga; tryptofan; valin; zinkacetatdihydrat - infusionsvätska, emulsion - natriumdivätefosfatdihydrat 2,34 mg aktiv substans; metionin 3,92 mg aktiv substans; glukosmonohydrat 176 mg aktiv substans; zinkacetatdihydrat 13,2 mikrog aktiv substans; omega-3-syratriglycerider 20 mg aktiv substans; sojaolja, raffinerad 80 mg aktiv substans; triglycerider, medellångkedjiga 100 mg aktiv substans; glycerol hjälpämne; lysinhydroklorid 5,68 mg aktiv substans; natriumacetattrihydrat 1,088 mg aktiv substans; kalciumkloriddihydrat 0,882 mg aktiv substans; glycin 3,3 mg aktiv substans; alanin 9,7 mg aktiv substans; serin 6 mg aktiv substans; leucin 6,26 mg aktiv substans; fenylalanin 7,02 mg aktiv substans; valin 5,2 mg aktiv substans; treonin 3,64 mg aktiv substans; tryptofan 1,14 mg aktiv substans; isoleucin 4,68 mg aktiv substans; arginin 5,4 mg aktiv substans; kaliumacetat 5,886 mg aktiv substans; magnesiumacetattetrahydrat 1,288 mg aktiv substans; prolin 6,8 mg aktiv substans; histidinhydrokloridmonohydrat 3,38 mg aktiv substans; natriumhydroxid 1,6 mg aktiv substans; asparaginsyra 3 mg aktiv substans; glutaminsyra 7 mg aktiv substans; natriumklorid 2,162 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

wick pharma, zweigniederlassung der procter & gamble gmbh - eukalyptusolja; kamfer, racemisk; levomentol; terpentinolja; tymol - salva - tymol 2,5 mg aktiv substans; kamfer, racemisk 50 mg aktiv substans; levomentol 27,5 mg aktiv substans; terpentinolja 50 mg aktiv substans; eukalyptusolja 15 mg aktiv substans - Övriga medel mot förkylning

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - kajeputolja; kamfer, racemisk; kryddnejlikolja; levomentol - salva - kryddnejlikolja 15 mg aktiv substans; kajeputolja 130 mg aktiv substans; kamfer, racemisk 100 mg aktiv substans; levomentol 120 mg aktiv substans - utvärtes medel vid led- och muskelsmärtor

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - kajeputolja; kamfer, racemisk; kryddnejlikolja; levomentol; myntaolja, delvis avmentoliserad - salva - levomentol 100 mg aktiv substans; kajeputolja 70 mg aktiv substans; kamfer, racemisk 110 mg aktiv substans; kryddnejlikolja 50 mg aktiv substans; myntaolja, delvis avmentoliserad 60 mg aktiv substans - utvärtes medel vid led- och muskelsmärtor

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

evolan pharma ab - kajeputolja; kamfer, racemisk; kryddnejlikolja; levomentol; myntaolja, delvis avmentoliserad - salva - levomentol 80 mg aktiv substans; myntaolja, delvis avmentoliserad 160 mg aktiv substans; kryddnejlikolja 15 mg aktiv substans; kajeputolja 130 mg aktiv substans; kamfer, racemisk 110 mg aktiv substans - utvärtes medel vid led- och muskelsmärtor